Speakers
Chris Arendt, Ph.D.
CSO, Head of Research
Takeda
David Baker, Ph.D.
Investigator, Howard Hughes Medical Institute and Professor, Biochemistry and Director, Institute for Protein Design
University of Washington
Trygve Bakken, M.D., Ph.D.
Associate Investigator
Allen Institute
Randal Bass, Ph.D.
Executive Vice President, Process Design & Biotherapeutic Operations
Just-Evotec Biologics
Tierney Baum, Ph.D.
Biopharma Analyst
BioCentury Inc.
Vanessa Bhark
Principal, Strategic Investment Fund
Gates Foundation
Melissa Bonner, Ph.D.
Chief Scientific Officer
nChroma Bio Inc.
Eliot Bourk, Ph.D.
Managing Director
Bourk BioAdvisors
Robert Bradley, Ph.D.
Scientific Director Translational Data Science Integrated Research Center (TDS IRC)
Fred Hutchinson Cancer Center
Gabriel Brooks, M.D.
Chief Medical Officer
Solid Biosciences
Mary Brunkow, Ph.D.
Senior Project Manager, Phenome Health and Program Manager, Genetics
Institute for Systems Biology
Matt DeFina
SVP, Regulatory Policy
Canal Row Advisors
Frank DiMaio, Ph.D.
Associate Professor
Institute for Protein Design
Jakob Dupont, M.D.
Executive Partner
Sofinnova Investments
Patrick Finn, Ph.D.
President and COO
Twist Bioscience
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Chris Garabedian
Portfolio Manager, PXV Fund and CEO,
Xontogeny
Hans‑Peter Gerber, Ph.D.
Chief Scientific Officer
Sutro Biopharma
DANIELLE GOLOVIN, PH.D.
Senior Biopharma Analyst
BioCentury Inc.
Claire Gustafson, Ph.D.
Assistant Investigator
Allen Institute for Immunology
Michelle Hoffmann, Ph.D.
Executive Director
Chicago Biomedical Consortium
Karen Knudsen, Ph.D.
CEO
Parker Institute for Cancer Immunology
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Julie Krop, M.D.
Chief Medical Officer
DiaMedica Therapeutics
Bryan Lafitte, Ph.D.
Executive Director Novartis Neuroscience & Head of Genetic Medicines
Novartis
Marc Lajoie, Ph. D.
CEO & Cofounder
Outpace
Ryan Larson, Ph.D.
SVP & Head of Research
Umoja Biopharma
Jeff Leek, Ph.D.
VP & Chief Data Officer
Fred Hutchinson Cancer Center
Ed Lein, Ph.D.
EVP and Director of Brain Health Accelerator
Allen Institute
Thomas Lynch, M.D.
President and Director
Fred Hutchinson Cancer Center
William McKeon
President & CEO
Texas Medical Center
Vishal Mehta
Founder & CEO
Ubuntu Research
Phil Moquist, Ph.D.
Director of ADC Chemistry
Pfizer
Ramlah Nehring, Ph.D.
Global Head of Partnerships and Transactions
Roche Diagnostics
Eric Olson, Ph.D.
Executive Director, Translational Systems Biology and Data Sciences
Borealis Biosciences
Ujjwal Ratan
Head of ML and Data Science, Healthcare & Life Sciences
Amazon Web Services
Klaus Romero, M.D.
CEO
Critical Path Institute
Michael Salgaller, Ph.D.
Supervisory Technology Analysis and Marketing Specialist
National Institutes of Health
Adrish Sannyasi
VP of Customer Solutions
Rhino Federated Computing
Jay Shendure, Ph.D., M.D.
Investigator, Howard Hughes Medical Institute and Professor of Genome Sciences
University of Washington
Swati Shree, MD
Associate Professor, Maternal Fetal Medicine Department of Obstetrics & Gynecology
University of Washington
Matthias Stephan, M.D., Ph.D.
Professor
Fred Hutchinson Cancer Center
Lesley Stolz, Ph.D.
Head of West North America, External Scientific Innovation
Johnson & Johnson Innovation
Katherine Stultz
CEO
BrainXell Therapeutics
Richard Tillyer, Ph.D.
Global Head, Discovery, Product Development and Supply
Johnson & Johnson Innovative Medicine
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Ben Weintraub, Ph.D.
President
inThought Research